Table 5. Clinical signs and symptoms observed in IBD case-series of patients in both countries.
| Mexico (n = 200) | Colombia (n = 201) | |||||
|---|---|---|---|---|---|---|
| Clinical signs and symptoms | Ulcerative Colitis (n = 120) | Crohn’s Disease (n = 80) | p* | Ulcerative Colitis (n = 165) | Crohn’s Disease (n = 35) | p* |
| Diarrhea n(%) | 118 (98.50) | 72 (90.00) | 0.01 | 151 (91.5) | 31 (86.1) | 0.85 |
| Rectal bleeding n(%) | 119 (99.20) | 72 (90.00) | 0.01 | 147 (89.1) | 24 (67.7) | 0.01 |
| Abdominal Pain n(%) | 92 (77.00) | 32 (40.00) | 0.06 | 127 (77) | 32 (88.9) | 0.1 |
| Weight Loss n(%) | 43 (35.83) | 52 (65.00) | <0.01 | 79 (47.9) | 23 (63.9) | 0.08 |
| Bowel obstruction n(%) | 17 (14.16) | 19 (23.75) | 0.07 | 11 (6.7) | 5 (13.9) | 0.05 |
| Anorexia n(%) | 24 (20.00) | 39 (48.75) | <0.01 | 42 (25.4) | 13 (36.1) | 0.04 |
| Fatigue n(%) | 37 (30.83) | 45 (56.25) | <0.01 | 8 (4.8) | 4 (11.1) | 0.23 |
| Others symptoms n(%) | 2 (1.74) | 11 (13.75) | 0.01 | 6 (3.6) | 0 | 0.5 |
| Arthritis/arthralgias n(%) | 66 (55.00) | 45 (56.25) | 0.76 | 9 (5.4) | 5 (13.9) | 0.05 |
* X2 tests